Código QR (código de barras bidimensional)

A Distinctive Metabolomics Pattern Associated with the Administration of Combined Sacubitril/Valsartan to Healthy Subjects: A Kinetic Approach

<b>Background/Objective:</b> Sacubitril/Valsartan are a combination drug approved for heart failure treatment, known to enhance natriuretic peptide activity and inhibit the renin–angiotensin–aldosterone system (RAAS). While its clinical efficacy is well-established, its broader impact on human metab...

תיאור מלא

שמור ב:
Principais autores: Randh AlAhmari, Hana M. A. Fakhoury, Reem AlMalki, Hatouf H. Sukkarieh, Lina Dahabiyeh, Tawfiq Arafat, Anas M. Abdel Rahman
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2025-08-01
סדרה:Pharmaceuticals
נושאים:
Sacubitril/Valsartan
metabolomics
LC-QToF HRMS
pyrimidine metabolism
pharmacokinetics
uridine triphosphate
גישה מקוונת:https://www.mdpi.com/1424-8247/18/9/1264
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים